Ndi Capital Inc. Insider Profile
4 Followers
Ndi Capital Inc., former Shareholder at Allon Therapeutics, holds 16.99M shares in Allon Therapeutics (Ticker: NPCUF). Most recently, Ndi Capital Inc. Bought 19,987,500 shares of Allon Therapeutics on Jun 25, 2012 for an estimated value of $5.00M.
Ndi Capital Inc.'s Trading History
| NPCUFAllon Therapeutics | Jun 25, 2012 | ― | Informative Buy | 5.00M | $849.44K | ||||||||||||||||||||||||||||||||||||
NPCUF
| |||||||||||||||||||||||||||||||||||||||||
You May Also Like
Ndi Capital Inc. insider profile FAQ
What is the percentage of profitable transactions made by Ndi Capital Inc.?
The percentage of profitable transactions made by Ndi Capital Inc. is 0%.
What is the average return per transaction made by Ndi Capital Inc.?
The average return per transaction made by Ndi Capital Inc. is -88.00%.
What stocks does Ndi Capital Inc. hold?
Ndi Capital Inc. holds: NPCUF stocks.
What was Ndi Capital Inc.’s latest transaction?
Ndi Capital Inc.’s latest transaction was an Informative Buy of $5.00M.
What was Ndi Capital Inc.'s most profitable transaction?
Ndi Capital Inc.’s most profitable transaction was an Informative Buy of NPCUF stock on June 25, 2012. The return on the trade was -87.20%.
What is Ndi Capital Inc.'s role in Allon Therapeutics?
Ndi Capital Inc.'s role in Allon Therapeutics is Shareholder.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
